Successful treatment of aggressive AA amyloidosis with tocilizumab in a patient with polymyalgia rheumatica
Küçük Resim Yok
Tarih
2024
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Oxford Univ Press
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Polymyalgia rheumatic (PMR) associated amyloidosis is an extremely rare condition that can be rapidly progressive with high morbidity and mortality and management is challenging. Tocilizumab is a monoclonal anti-IL-6 receptor antibody, which is in the therapeutic arsenal of PMR. The efficiency of tocilizumab in improvement of PMR activity score and decreasing steroid dose is well-established, while efficiency in PMR-associated amyloidosis has not been published. Herein, we reported a PMR patient with amyloid A amyloidosis who was treated effectively with tocilizumab.
Açıklama
Anahtar Kelimeler
Polymyalgia rheumatica, AA amyloidosis, tocilizumab, IL-6, proteinuria
Kaynak
Modern Rheumatology Case Reports
WoS Q Değeri
Q4
Scopus Q Değeri
Q3
Cilt
9
Sayı
1
